Rheumatology.net

Rheumatology Xagena

Xagena Mappa
Medical Meeting
Pneumobase.it
Neurobase.it

Search results for "Tanezumab"

Results from a phase 3 study evaluating Tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis ( OA ) pain were presented. Tanezumab 5 mg treatment arm met all three co-primary ...